Login / Signup

A Transcription Factor-Based Risk Model for Predicting the Prognosis of Prostate Cancer and Potential Therapeutic Drugs.

Ruixiang LuoMengjun HuangYinghuai Wang
Published in: Evidence-based complementary and alternative medicine : eCAM (2021)
Ten genes of both high-and low-risk scores were associated with the prognosis of PC. PC prognosis may be related to immune disorders. SPOP, TP53, and TTN may be potential targets for the prognosis of PC.
Keyphrases
  • prostate cancer
  • transcription factor
  • radical prostatectomy
  • gene expression
  • genome wide
  • risk assessment
  • genome wide identification
  • dna binding
  • breast cancer risk